Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
HNRNPH1 variants have been implicated in autosomal dominant neurodevelopmental disorder. A male proband presented with dysmorphy, developmental delay, intellectual disability, autism spectrum disorder, hypotonia, and seizures, harboring a de novo heterozygous c.616C>T (p.Arg206Trp) variant in HNRNPH1 (PMID:29938792). A multi-cohort sequencing study of hnRNP family genes identified HNRNPH1 among 12 candidate NDD genes across 119 new cases, supporting its role in cortical development (PMID:33874999). No further familial segregation has been reported.
Direct functional characterization of HNRNPH1 variants in neurodevelopmental contexts is lacking. Expression profiling indicates enriched hnRNP expression in radial glial progenitors, and murine models show genetic compensation of Hnrnph2 by Hnrnph1 (PMID:37463454), suggesting functional overlap. Further in vitro or in vivo studies are needed to define pathogenic mechanisms. Key take-home: De novo HNRNPH1 variants present limited but compelling evidence for autosomal dominant neurodevelopmental disorder; additional work will clarify diagnostic and therapeutic potential.
Gene–Disease AssociationLimitedSingle de novo proband with concordant dysmorphy and neurodevelopmental features; candidate gene support from multi-cohort hnRNP NDD study (119 cases) Genetic EvidenceLimitedOne de novo c.616C>T variant in HNRNPH1 with no additional segregation Functional EvidenceLimitedAbsence of direct functional assays in neuronal models; paralogue compensation in mouse suggests overlapping function |